Abstract Details
Christiane Reitz, MD, PhD
(Columbia University)
PRESENTER |
No disclosure on file |
No disclosure on file | |
Badri Vardarajan | Badri Vardarajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kodikaz Therapeutics. |
Martin A. Kohli (University of Miami) | No disclosure on file |
Brian D. Moseley, MD | Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has stock in UCB. Dr. Moseley has stock in Neurocrine Biosciences. |
Adam Naj, PhD | No disclosure on file |
Patrice Whitehead | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
Gary W. Beecham, PhD (University of Miami, Hussman Institute for Human Genomics) | The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH. |
No disclosure on file | |
Lindsay A. Farrer, MD (Boston Univ School of Medicine) | No disclosure on file |
Jonathan Haines, MD (Vanderbilt University) | No disclosure on file |
Gerard Schellenberg, PhD | No disclosure on file |
Margaret A. Pericak-Vance, PhD (University of Miami Miller School of Medicine) | Dr. Pericak-Vance has nothing to disclose. |
Richard P. Mayeux, MD, MSc, FAAN (The Neurological Institute, Columbia University Medical Center) | Dr. Mayeux has nothing to disclose. |